1.
Khalid Al Hawsawi, Bashair Al Zahrani, Hawazin Jan, Duaa Babkoor, Razan Alluhaibi, Emad Alharbi. Omalizumab in Chronic Spontaneous Urticaria: Assessment of Response in Twenty-Five Patients. DER [Internet]. 2022 Jan. 20 [cited 2026 Aug. 26];7(1):1-5. Available from: https://openventio.us/index.php/DER/article/view/1304